CCA
Cravens & Co Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,866
| Closed | -$1.02M | – | 56 |
|
|
2025
Q1 | $1.02M | Sell |
4,866
-103
| -2% | -$21.6K | 0.79% | 29 |
|
|
2024
Q4 | $883K | Buy |
4,969
+107
| +2% | +$19K | 0.67% | 30 |
|
|
2024
Q3 | $960K | Sell |
4,862
-2,041
| -30% | -$403K | 0.74% | 32 |
|
|
2024
Q2 | $1.18M | Buy |
6,903
+515
| +8% | +$88.3K | 0.88% | 20 |
|
|
2024
Q1 | $1.16M | Sell |
6,388
-68
| -1% | -$12.4K | 0.97% | 24 |
|
|
2023
Q4 | $1M | Sell |
6,456
-100
| -2% | -$15.5K | 0.86% | 25 |
|
|
2023
Q3 | $977K | Buy |
6,556
+89
| +1% | +$13.3K | 0.92% | 23 |
|
|
2023
Q2 | $871K | Sell |
6,467
-9
| -0.1% | -$1.21K | 0.8% | 27 |
|
|
2023
Q1 | $1.03M | Buy |
6,476
+26
| +0.4% | +$4.14K | 0.96% | 15 |
|
|
2022
Q4 | $1.04M | Buy |
+6,450
| New | +$1.04M | 0.96% | 16 |
|